Kaido, Minako
Arita, Reiko
Clinical trials referenced in this document:
Documents that mention this clinical trial
Effects of a Long-Acting Diquafosol Ophthalmic Solution on the Ocular Surface, Tolerability, and Usability in Dry Eye Disease
https://doi.org/10.1007/s12325-024-02871-4
Article History
Received: 6 February 2024
Accepted: 5 April 2024
First Online: 6 May 2024
Declarations
:
: Santen Pharmaceutical Co., Ltd (Osaka, Japan) was not involved in the scientific content of the research project or the writing of the manuscript. Minako Kaido and Reiko Arita declare that they have no competing interests.
: The study protocol was reviewed and approved by the Ethics Committee of the Institutional Review Board of the Itoh Clinic, Saitama, Japan (Registry ID: 2022-1205). All procedures were performed in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and the Helsinki Declaration of 1964, as revised in 2013. Informed consent was obtained from all participants. This study was registered with the University Hospital Medical Information Network (Registry ID: UMIN000051390).
: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.